|
Indian Pediatr 2010;47: 661-665 |
|
Consensus Statement: National Consensus
Workshop on Management of SAM Children through Medical Nutrition
Therapy |
Writing Committee: HPS Sachdev, Umesh Kapil and Sheila Vir
Correspondence to: Prof HPS Sachdev, Senior Consultant
Pediatrics and Clinical Epidemiology, Sitaram Bhartia Institute of Science
and Research, B-16 Qutab Institutional Area, New Delhi 110 016, India.
Email: [email protected]
|
Justification: Severe acute malnutrition (SAM) is an important
preventable and treatable cause of morbidity and mortality in children
below five years of age in India. The concerned stakeholders are not in
agreement about the role of product based medical nutrition therapy in
the management of this condition.
Process: In November 2009, a National Consensus
Workshop was organized by the Department of Human Nutrition, All India
Institute of Medical Sciences, New Delhi in collaboration with the
Department of Pediatrics and Clinical Epidemiology, Sitaram Bhartia
Institute of Science and Research, New Delhi, and the Sub-specialty
Chapter on Nutrition, Indian Academy of Pediatrics. Presentations by
eminent national and international scientists, the ensuing discussions,
and opinions expressed by the participants provided the basic framework
for drafting the consensus statement. The draft of the consensus
statement was circulated to all the participants; it underwent two
revisions after consideration of their comments.
Objectives: (i) Critically appraise the
current global evidence on the utility of "Medical Nutrition Therapy" (MNT)
for the management of SAM in under five children; (ii) Formulate
a consensus amongst stakeholders regarding the need to introduce product
based MNT for the management of SAM in under five children in India; (iii)
Identify research priorities for MNT for the management of SAM in under
five children in India; and (iv) Ascertain potential challenges
for introducing product based MNT in India, if consensus opinion
identifies such a need.
Recommendations: Guidelines related to the role
of MNT in management of children suffering from SAM are presented.
Global and regional data document the effectiveness of MNT using
ready-to-use therapeutic foods (RUTF) and locally formulated products.
Adequate caution should be exercised to ensure that MNT for SAM does not
interfere with measures for the holistic prevention of childhood
undernutrition. Indian manufacture of RUTF is feasible, and can be
scaled up. Product-based nutrition therapy including RUTF can be
introduced on a pilot basis when a delivery design and plan of action is
developed and is in place as a part of the larger system to deal with
childhood undernutrition. RUTF should be used only as therapeutic and
not supplementary feeding, above six months of age, and for a limited
time period (4-8 weeks) until the child recovers from SAM, which should
be defined in explicit treatment protocols. An urgent research issue is
comparison of RUTF with home-based and locally-formulated products.
Keywords: Child malnutrition, Nutrition therapy, Ready-to-use
therapeutic foods.
|
S evere acute malnutrition (SAM) is
an important preventable and treatable cause of morbidity and mortality in
children below five years of age in India. The concerned stakeholders are
not in agreement about the role of product based medical nutrition therapy
in management of children suffering from this condition. In an attempt to
resolve this disagreement, the Department of Human Nutrition, All India
Institute of Medical Sciences, New Delhi in collaboration with the
Department of Pediatrics and Clinical Epidemiology, Sitaram Bhartia
Institute of Science and Research, New Delhi, and the Sub-specialty
Chapter on Nutrition, Indian Academy of Pediatrics, organized a National
Consensus Work-shop on Management of SAM Children through Medical
Nutrition Therapy. This Workshop was funded by the Department of
Biotechnology, Government of India and the Indian Council of Medical
Research, Government of India. The Workshop was held from November 26 to
27, 2009 at the All India Institute of Medical Sciences, New Delhi with
the following objectives: (i) critically appraise the current
global evidence on the utility of "Medical Nutrition Therapy" (MNT) for
the management of Severe Acute Malnutrition (SAM) in under five children;
(ii) formulate a consensus amongst stakeholders regarding the need
to introduce product based "Medical Nutrition Therapy" for the management
of Severe Acute Malnutrition in under five children in India; (iii)
identify research priorities for "Medical Nutrition Therapy" for the
management of Severe Acute Malnutrition in under five children in India;
and (iv) ascertain potential challenges for introducing product
based "Medical Nutrition Therapy" in India, if consensus opinion
identifies such a need.
The invited participants are listed in the
Appendix. Eminent national and
international scientists were requested to prepare evidence based state of
the art presentations on relevant issues identified by the Organizing
Committee. These presentations, the ensuing discussions, and opinions
expressed by the participants provided the basic input for drafting the
consensus statement. The first draft of the consensus statement was
circulated to all the participants for their comments. A second draft was
developed after receiving their comments. The second draft was again
circulated for comments to all participants. Following this, the finalized
third version of the consensus statement was developed, which was approved
by the majority of the participants. 1
Consensus Statement
• In India, 8.1 million children are estimated to
suffer from severe acute malnutrition (SAM). 2
In a nation marching ahead on the economic front, the magnitude and
serious consequences of SAM among children makes it unethical not to
urgently initiate measures to prevent and treat SAM. Protecting lives
and promoting optimum development of SAM children is also a human rights
issue.
• Up to 15% under-5 children with SAM require
inpatient management because of medical complications. The remaining 85%
(without medical complications) can be managed through a community-
and/or home-based care approach.
• There is an urgent need to update both facility-
and home-based care recommendations for the management of SAM among
children in India, on the basis of latest evidence.
• Medical Nutrition Therapy (MNT) is only a component
of the entire process of managing SAM children and being a time-limited
therapeutic intervention, it should not be viewed as being in conflict
with the objective and accepted process of attaining food and nutrition
security or promoting appropriate Infant and Young Child Feeding (IYCF)
practices for children with or without SAM. However, adequate caution
should be exercised to ensure that MNT for SAM does not interfere with
measures for the holistic prevention of childhood undernutrition.
• Ready to Use Therapeutic Food (RUTF) as per WHO and
UNICEF specifications 3 is a
Medical Nutrition Therapy based on sound scientific principles with a
balanced composition of type I and type II nutrients. Apart from
anthropometric recovery, RUTF results in physiological and functional
(including immunological) recovery. It has a specific composition which
has been tested and proved effective in functional recovery of SAM
children. RUTF should not be confused with ready to use food (RTUF) or
any other products or preparations.
• Global evidence, primarily from Africa, indicates
that RUTF-based nutrition therapy is effective for facility- and
home-based management of SAM children who do not have medical
complications, and can be scaled up for community or home-based
management for children over six months of age.
• Pilot experience from India (Bihar and Madhya
Pradesh) suggests that RUTF is effective for nutritional therapy of SAM
children and can also be scaled up. Similar experience from Maharashtra
has been reported with other locally formulated products. Other models
from West Bengal and Gujarat, on a smaller scale, have also showed
similar weight gains with locally formulated products. There is a
suggestion from observational data in Madhya Pradesh that RUTF may be
superior to standard treatment with F-100 and IAP formulations. However,
there is no head to head comparison of effectiveness of RUTF with
locally formulated products. Further, all of these experiences from
India relate to weight gain and not to height gain or physiological or
functional recovery.
• A qualitative study undertaken in mid 2009 from six
states of India suggests that against the backdrop of fragile food
security and faulty feeding practices, mothers who are time constrained
tend to reach out to market foods to feed their children, which may be
of sub-optimal nutrition quality. Further, the families do not recognize
the signs of undernutrition until children develop severe malnutrition
and medical complications.
• Considerable sensitivities exist regarding the
possibility of commercial exploitation of undernutrition through
aggressive marketing and supply of international product-based nutrition
therapy and erosion of: (i) exclusive breastfeeding during the
first six months of life, and (ii) continued breastfeeding
between 6 and 24 months of life. Further, any action has to be in
consonance with the Infant Milk Substitutes Feeding Bottles, and Infant
Foods (Regulation of Production, Supply and Distribution) Act 1992 as
amended in 2003 (IMS Act) (http://www.bpni.org/docments/IMS-act.pdf)
and the Supreme Court orders on the Right to Food Act (www.righttofoodindia.org
and www. sccommissioners.org).
• Indian manufacture of RUTF is feasible, can be
scaled up and even industrial production for export has been started by
at least a couple of units. The fear of commercialization can be
obviated by following principles of: (i) non-proprietary product;
(ii) partially decentralized manufacture with public sector
involvement; (iii) public health system being the sole
procurement agency with a specific strategy that ensures purchase from
multiple producers; and (iv) prescribed product, which is not
freely available.
• Product-based nutrition therapy including RUTF can
be introduced on a pilot basis at scale (district or state level)
utilizing existing systems for sustainability. The pilot project should
be introduced when a delivery design and plan of action is developed and
is in place as a part of the larger system to deal with childhood
undernutrition. RUTF should be used only:
– As therapeutic and not supplementary feeding
– Above six months of age
– For a limited time period (4-8 weeks) until the
child recovers from SAM, which should be defined in explicit treatment
protocols
• MNT could be operationalized by the Health Ministry
through the Integrated Management of Newborn and Childhood Illnesses (IMNCI)
module, which also has a component for the management of SAM. The
Integrated Child Development Services (ICDS) system could converge for
the identification and referral of children with SAM and the follow up
of these children after their discharge from therapeutic feeding.
• To aid the evaluation process in an observational
manner, outcome measures should be recorded after some time of
operationalization of intervention program and include follow-up of
rehabilitated children.
• Regulatory issues would need to be resolved between
the two nodal authorities (Drug Controller General of India and Food
Safety and Standards Authority of India) before MNT can be
operationalized. The feasibility of manu-facturing, regulation and
registration as a food and use and distribution as a drug should be
explored.
• Food and nutrition security and preventive aspects
should be ensured during treatment for and after recovery from SAM to
prevent relapses.
• Urgent research issues include:
– Comparison of RUTF with home-based
and locally-formulated products
– Physiological recovery and longer benefits of the
above treatments
– Effect of introduction of RUTF on breast feeding
– Operationalization and economic analysis in
different settings
Contributors: HPSS, UK and SV were the
designated writing committee members for this workshop. HPSS composed the
first draft of this statement, which after input from UK and SV was
circulated to all the participants. A similar process was followed for the
second and final drafts for circulation to all participants.
Funding: Department of Biotechnology, Indian
Council of Medical Research, World Health Organization (India Country
Office) and World Food Programme (India Country Office).
Competing interests: None stated.
Appendix
List of Invited Participants
Agarwal Vandana, Nutrition Specialist, UNICEF; *Agarwal
KN, Ex-Professor of Pediatrics, New Delhi; Agnani Manohar, Commissioner
Health, Madhya Pradesh; Aguayo Victor, Chief, Child Nutrition &
Development; UNICEF; Aiyer Sheila, Govt. Medical College, Baroda; *Anand
VK, WHO, New Delhi; Arora Narendra, Executive Director, INCLEN, New
Delhi; *Arora Mahesh, Director, Ministry of Women and Child Health, New
Delhi; Ayoya Mohamed Ag, Nutrition Specialist, UNICEF; *Bagchi Kunal,
Advisor, WHO SEAR, New Delhi; *Banapurmath CR, Professor of Pediatrics,
Davangere; Bavdekar Sandeep, Professor of Paediatrics, GS Medical Collge,
Mumbai; Bhan MK, Secretary, Department of Biotechnology; New Delhi;
Bhandari Nita, Joint Director, Society for Applied Studies, New Delhi;
Bhatnagar Shinjini, Senior Research Scientist, AIIMS, New Delhi; Bose
Anuradha, Professor, Department of Pediatrics, CMC, Vellore; Briend
André, Former Medical Officer, World Health Organization, *Chakravarty
Indira, Member, Food Safety and Standards Authority, Govt. of India;
Chandola Temsunaro Rongsen, Senior Scientist, Society for Applied
Studies, New Delhi; Chaudhary Nidhi, National Professional Officer, WHO,
New Delhi; *Chellani Harish, Pediatrician, Safdarjung Hospital, New
Delhi; Choudhury Panna, Consultant Pediatrician, New Delhi; Collins
Steve, Director, Valid International, Oxford; Dalwai Samir, Consulting
Paediatrician, Mumbai; Doyon Stéphane, Nutrition - Access Campaign
(CAME), Médecins Sans Frontières; Dubey AP, President,IAP- Sub-Specialty
Chapter on Nutrition, New Delhi; Gera Tarun, Pediatrician, New Delhi;
Gite Naresh, Director(Monitoring), Govern-ment of Maharashtra; Golden
Mike, Emeritus Prof. of Pediatrics, Ireland; Gupta Arun, Regional Co-ordinator,
IBFAN Asia, New Delhi; *Gupta Piyush, Editor-in-chief, Indian
Pediatrics, New Delhi; Hariprasad Deepali, Sr. Program Officer, Maternal
& Child Health/Nutrition, New Delhi; Heldal Jan Are, Technical Advisor,
Compact AS, Norway; Jarrett Stephen, Principal Adviser, UNICEF, New
York; Kapil Umesh, Professor, Department of Human Nutrition, AIIMS, New
Delhi; Kapur Rajesh, Adviser (Food & Nutrition), Department of
Biotechnology, New Delhi; Kashyap Sushma, Associate Professor, Lady
Irwin College, New Delhi; Katoch VM, Director General, Indian Council of
Medical Research, New Delhi; Khanna Kumud, Director, Institute of Home
Economics, New Delhi; Kotecha Prakash V, Technical Advisor, USAID, New
Delhi; Kulkarni Bharati, Scientist C, National Institute of Nutrition,
Hyderabad; Kumar Praveen, Professor of Pediatrics, LHMC, New Delhi;
Kurpad Anura V, Dean, Institute of Popualtion Health and Clinical
Research, Bangalore; Laxmaiah A; Deputy Director, National Institute of
Nutrition, Hyderabad; Lodha Rakesh, Assistant Professor in Pediatrics,
AIIMS, New Delhi; Manary MJ, Washington University School of Medicine,
USA; *Marwah Kumkum, Joint Technical Adviser, New Delhi; *Mathew Minnie,
UNICEF, New Delhi; Mcilvenna Matthew, Deputy Country Director, UN-World
Food Programme, New Delhi; Mehta Rajesh, WHO, India; Mouli Uma Chandra,
Institute of Translation Medicine, Department of Biotechnology,
Faridabad; Nair K Madhavan, Micronutrient Research Group, Department of
Biophysics, Hyderabad; Narayan Sushma, Kasturba Hospital, New Delhi; Pal
Subhomay, Consultant, CINI, Kolkata; Patnaik Biraj, Principal Advisor,
Office of the Commissioner to the Supreme Court, New Delhi; Patwari
Ashok K, MCH- STAR Initiative, New Delhi; Prakash V, Director, Central
Food Technological Research Institute, Mysore; *Prakash Vijoy, Principal
Secretary, Rural Development, Patna, Bihar; Raj Kamal, Nutrition
Specialist, UNICEF-India, New Delhi; Ramji Siddarth, Professor of
Pedaitrics, New Delhi; Rasaily Reeta, Deputy Director General, ICMR, New
Delhi; Roy D, Deputy Drugs Controller (India), New Delhi; Sachdev HPS,
Senior Consultant Pediatrics, New Delhi; *Sethi NK, Senior Advisor
(Health), Planning Commission, India; Shah Dheeraj, University College
of Medical Sciences, Delhi; Shreeranjan, Joint Secretary Ministry of
Women and Child Development, Government of India, New Delhi; Srivastava
RK; Director General Health Services, New Delhi; Tamamura Mihoko,
Country Director and Representative, UN-World Food Programme, New Delhi;
Tandon Rajiv, Chief-MCH, USAID, New Delhi; *Tiwari BK, Advisor (Food and
Nutrition), DGHS, New Delhi; Toteja GS, ICMR, New Delhi; Vir Sheila,
Public Nutrition and Development Center, New Delhi; Yadav Birendra
Prasad, District Magistrate, Madhepura; and *Yunus Shariqua, World Food
Program, New Delhi.
*could not participate.
|
|
|
|